gatifloxacin has been researched along with Infection, Postoperative Wound in 7 studies
Gatifloxacin: A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS.
gatifloxacin : A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Moxifloxacin, given in the same dosage, penetrated the aqueous humour better then gatifloxacin during cataract surgery." | 5.15 | Aqueous humour penetration of moxifloxocin and gatifloxacin eye drops in different dosing regimens before phacoemulsification surgery. ( Akova, YA; Babaoğlu, MÖ; Bozkurt, A; Çetinkaya, A; Çolak, M; Güngör, SG; Yasar, Ü, 2011) |
| "To evaluate the ocular surface and aqueous antimicrobial effects of gatifloxacin and moxifloxacin administered in two dosing regimens to patients undergoing phacoemulsification." | 2.73 | Antimicrobial efficacy of prophylactic gatifloxacin 0.3% and moxifloxacin 0.5% in patients undergoing phacoemulsification surgery. ( Amico, LM; Bucci, FA; Evans, RE, 2008) |
| "Gatifloxacin was active against streptococci, Escherichia coli, Klebsiella pneumoniae, Moraxella catarrhalis, Haemophilus influenzae and Neisseria gonorrhoeae, with MIC(90)s of | 1.31 | In vitro antimicrobial activity of gatifloxacin against 873 clinical isolates from respiratory tract, urinary tract and surgical infections during 1997-1998 in Japan. ( Hosaka, M; Manda, H; Takei, M; Tsurumaki, Y, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kobayakawa, S | 1 |
| Ooki, K | 1 |
| Tsuji, A | 1 |
| Tochikubo, T | 1 |
| Shin, JH | 1 |
| Lee, HB | 1 |
| Park, HY | 1 |
| Güngör, SG | 1 |
| Akova, YA | 1 |
| Bozkurt, A | 1 |
| Yasar, Ü | 1 |
| Babaoğlu, MÖ | 1 |
| Çetinkaya, A | 1 |
| Çolak, M | 1 |
| Donnenfeld, RS | 1 |
| Perry, HD | 1 |
| Solomon, R | 1 |
| Jensen, HG | 1 |
| Stein, J | 1 |
| Snyder, RW | 1 |
| Wittpenn, JR | 1 |
| Donnenfeld, ED | 1 |
| de la Cruz, J | 1 |
| Behlau, I | 1 |
| Pineda, R | 1 |
| Bucci, FA | 1 |
| Amico, LM | 1 |
| Evans, RE | 1 |
| Tsurumaki, Y | 1 |
| Manda, H | 1 |
| Takei, M | 1 |
| Hosaka, M | 1 |
3 trials available for gatifloxacin and Infection, Postoperative Wound
| Article | Year |
|---|---|
Comparison of the effects of fourth-generation fluoroquinolones on epithelial healing after photorefractive keratectomy.
Topics: Administration, Topical; Adult; Anti-Infective Agents; Aza Compounds; Double-Blind Method; Female; F | 2010 |
Aqueous humour penetration of moxifloxocin and gatifloxacin eye drops in different dosing regimens before phacoemulsification surgery.
Topics: Aged; Anti-Infective Agents; Aqueous Humor; Aza Compounds; Cataract; Chromatography, High Pressure L | 2011 |
Antimicrobial efficacy of prophylactic gatifloxacin 0.3% and moxifloxacin 0.5% in patients undergoing phacoemulsification surgery.
Topics: Anti-Infective Agents; Antibiotic Prophylaxis; Antitubercular Agents; Aqueous Humor; Aza Compounds; | 2008 |
4 other studies available for gatifloxacin and Infection, Postoperative Wound
| Article | Year |
|---|---|
Aqueous humor penetration of fourth-generation fluoroquinolone ophthalmic solutions given by multiple administration in a rabbit model.
Topics: Animals; Anti-Bacterial Agents; Aqueous Humor; Aza Compounds; Cataract Extraction; Drug Administrati | 2009 |
A comparison of gatifloxacin to ciprofloxacin in the prophylaxis of Streptococcus pneumoniae in rabbits in a LASIK model.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Cornea; Disease Models, Animal; Eye Infections, Bacte | 2006 |
Atypical mycobacteria keratitis after laser in situ keratomileusis unresponsive to fourth-generation fluoroquinolone therapy.
Topics: Adult; Anti-Infective Agents; Clarithromycin; Drug Resistance, Bacterial; Eye Infections, Bacterial; | 2007 |
In vitro antimicrobial activity of gatifloxacin against 873 clinical isolates from respiratory tract, urinary tract and surgical infections during 1997-1998 in Japan.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Fluoroquinolones; Gatifloxacin; Humans; Japa | 2000 |